BAT1706
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BAT1706, covering 2018-07-30 to 2025-02-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study Investigating the Efficacy and Safety of Ociperlimab and Tislelizumab and BAT1706 Combinations in Patients With Advanced HCC [Phase 2]